The 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit) served as a launchpad for innovation
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
Launch Represents Significant Step to Broader Commercialization
RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox
Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization
SALT LAKE CITY, February 26, 2026— ARUP Laboratories, a leader in diagnostic medicine and the largest nonprofit reference laboratory in the U.S., today announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners. The Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating […]
Twelve rising startups have been selected to present their innovations to investors during the 2026 Entrepreneur & Investor Life Sciences Summit on March 12, sponsored by Wilson Sonsini. Salt Lake City, February 20, 2026—BioUtah, Utah’s trade association dedicated solely to the life sciences, in partnership with Brigham Young University’s (BYU) Technology Transfer Office and College […]
RadSep, Inc., a subsidiary of IBC Advanced Technologies, Inc., provides state-of-the-art purification technology and novel chelators for medical radioisotopes and their precursors (Ac-225, Ra-224, Ra-225, Ra-226, Ra-228, Th-228, Th-232, Pb-212, Cu-67, and more). RadSep offers Molecular Recognition Technology™ (MRT™) resins that are extremely selective, stable and simple to use. First-pass recoveries and purities of 99.9+% […]
CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution
Cytiva Sponsors Operational Excellence Case Study Competition
Featuring exhibits from over 20 local companies, including medical device, diagnostics, and biotech companies.
First podium presentation of IDE Clinical Trial Data of Novel Embolic Device to Treat Cancer
Senator Lee’s Deputy chief of staff Justin Anthony yesterday toured the new James LeVoy Sorenson Center for Medical Innovation (SCMI) at the University of Utah. The four-story, nearly 60,000-square-foot facility, led by Executive Director, Mark Paul, features advanced prototyping labs, a clinical bio-tissue surgery suite, and incubator spaces designed to foster, develop, and commercialize next-generation […]
Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay
Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data.
Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies
Behavioral Health Assessment Using Vocal Biomarkers
Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West
Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep – evaluating bedtimes, wake-ups, sleep stretches, and biometric trends
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease
SPARC Health, a collaborative effort between Park City Angels (PCA), BioUtah, BioHive, in partnership with Governor’s Office of Economic Opportunity (GOEO), announced applications are now open for its second cohort program.
Taking place on March 12, 2026, at the Hilton Salt Lake City Center, the competition provides early-stage healthcare companies with a premier platform to showcase innovations to experienced investors and industry leaders.
Check out the photo gallery from the 2026 JP Morgan Healthcare conference in San Francisco.
The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.
State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026
DiscGenics Treats First Patient in Phase 3 Clinical Trial of IDCT (Rebonuputemcel) for Symptomatic Mild-to-Moderate Lumbar Degenerative Disc Disease
Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions.
Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment
Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professor, to advise the Company on immunological strategies for its novel cancer treatment platform.
Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing
